Search details
1.
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus identifies germline-somatic interactions with EWSR1-FLI1 binding.
Am J Hum Genet
; 110(3): 427-441, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36787739
2.
Renal toxicity of ifosfamide in children with cancer: an exploratory study integrating aldehyde dehydrogenase enzymatic activity data and a wide-array urinary metabolomics approach.
BMC Pediatr
; 24(1): 196, 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38504218
3.
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Int J Cancer
; 152(8): 1659-1667, 2023 04 15.
Article
in English
| MEDLINE | ID: mdl-36250317
4.
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Lancet
; 400(10362): 1513-1521, 2022 10 29.
Article
in English
| MEDLINE | ID: mdl-36522207
5.
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.
BMC Cancer
; 23(1): 69, 2023 Jan 20.
Article
in English
| MEDLINE | ID: mdl-36670431
6.
Molecular and clinicopathologic characterization of pediatric histiocytoses.
Am J Hematol
; 98(7): 1058-1069, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37115038
7.
Desmoplastic Small Round Cell Tumors With EWS-WT1 Transcript Expression: Should We Consider Children and Adult Patients Differently?
J Pediatr Hematol Oncol
; 44(3): e637-e642, 2022 Apr 01.
Article
in English
| MEDLINE | ID: mdl-34310472
8.
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncol
; 22(9): 1312-1321, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34416158
9.
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 446-455, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32078813
10.
Efficacy and Tolerance of Lidocaine 5% Patches in Neuropathic Pain and Pain Related to Vaso-occlusive Sickle Cell Crises in Children: A Prospective Multicenter Clinical Study.
Pain Pract
; 18(6): 788-797, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29266772
11.
Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
BMC Cancer
; 17(1): 419, 2017 Jun 15.
Article
in English
| MEDLINE | ID: mdl-28619014
12.
Percutaneous guided biopsy for diagnosing suspected primary malignant bone tumors in pediatric patients: a safe, accurate, and cost-saving procedure.
Pediatr Radiol
; 47(2): 235-244, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27942776
13.
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 17(8): 1070-1080, 2016 Aug.
Article
in English
| MEDLINE | ID: mdl-27324280
14.
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).
BMC Cancer
; 15: 854, 2015 Nov 05.
Article
in English
| MEDLINE | ID: mdl-26541413
15.
Primary cutaneous and subcutaneous Ewing sarcoma.
Pediatr Blood Cancer
; 62(9): 1555-61, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25894676
16.
Sarcoma Occurring at the Site of Growth Hormone Therapy.
J Pediatr Hematol Oncol
; 42(4): 335, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32251155
17.
De novo radiologic placement of button gastrostomy: a feasibility study in children with cancer.
Pediatr Radiol
; 45(13): 1957-63, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26209960
18.
HEDEN Pain Scale: A Shortened Behavioral Scale for Assessment of Prolonged Cancer or Postsurgical Pain in Children Aged 2 to 6 Years.
Pediatr Hematol Oncol
; 32(5): 291-303, 2015.
Article
in English
| MEDLINE | ID: mdl-25871337
19.
The off-label use of targeted therapies in sarcomas: the OUTC'S program.
BMC Cancer
; 14: 870, 2014 Nov 24.
Article
in English
| MEDLINE | ID: mdl-25420707
20.
An Integrated Cancer Prevention Strategy: the Viewpoint of the Leon Berard Comprehensive Cancer Center Lyon, France.
Cancer Prev Res (Phila)
; 17(4): 133-140, 2024 Apr 02.
Article
in English
| MEDLINE | ID: mdl-38562091